Eagle Pharmaceuticals, Inc. (EGRX)

USD 1.96

(30.67%)

Eps Summary of Eagle Pharmaceuticals, Inc.

Eagle Pharmaceuticals, Inc.'s latest annual eps in 2022 was 2.76 USD , up 518.18% from previous year.
Eagle Pharmaceuticals, Inc.'s latest quarterly eps in 2023 Q2 was 0.39 USD , down -11.36% from previous quarter.
Eagle Pharmaceuticals, Inc. reported an annual eps of -0.66 USD in 2021, down -174.16% from previous year.
Eagle Pharmaceuticals, Inc. reported an annual eps of 0.89 USD in 2020, down -14.42% from previous year.
Eagle Pharmaceuticals, Inc. reported a quarterly eps of 0.44 USD for 2023 Q1, down -30.16% from previous quarter.
Eagle Pharmaceuticals, Inc. reported a quarterly eps of 3.47 USD for 2022 Q1, up 822.92% from previous quarter.

Annual Eps Chart of Eagle Pharmaceuticals, Inc. (2022 - 2012)

Historical Annual Eps of Eagle Pharmaceuticals, Inc. (2022 - 2012)

Year	Eps	Eps Growth
2022	2.76 USD	518.18%
2021	-0.66 USD	-174.16%
2020	0.89 USD	-14.42%
2019	1.04 USD	-51.85%
2018	2.16 USD	-37.21%
2017	3.44 USD	-34.35%
2016	5.24 USD	2982.35%
2015	0.17 USD	109.39%
2014	-1.81 USD	-217.54%
2013	-0.57 USD	68.85%
2012	-1.83 USD	0.0%

Year	Eps	Eps Growth
2023 Q2	0.39 USD	-11.36%
2023 Q1	0.44 USD	-30.16%
2022 Q1	3.47 USD	822.92%
2022 FY	- USD	518.18%
2022 Q2	-0.74 USD	-121.33%
2022 Q3	-0.27 USD	63.51%
2022 Q4	0.63 USD	333.33%
2021 FY	- USD	-174.16%
2021 Q3	-0.43 USD	-253.57%
2021 Q4	-0.48 USD	-11.63%
2021 Q2	0.28 USD	969.57%
2021 Q1	-0.03 USD	-105.37%
2020 Q3	0.52 USD	2880.75%
2020 Q1	-0.21 USD	-400.0%
2020 Q2	-0.02 USD	91.1%
2020 Q4	0.60 USD	15.38%
2020 FY	- USD	-14.42%
2019 Q2	0.49 USD	-23.44%
2019 Q4	0.07 USD	141.18%
2019 Q3	-0.17 USD	-134.69%
2019 FY	- USD	-51.85%
2019 Q1	0.64 USD	-27.27%
2018 Q3	0.94 USD	422.22%
2018 Q2	0.18 USD	0.0%
2018 Q1	0.18 USD	-70.49%
2018 FY	- USD	-37.21%
2018 Q4	0.88 USD	-6.38%
2017 Q4	0.61 USD	-40.78%
2017 Q2	0.30 USD	-80.0%
2017 Q1	1.50 USD	-60.0%
2017 FY	- USD	-34.35%
2017 Q3	1.03 USD	243.33%
2016 Q1	-0.06 USD	-175.0%
2016 Q4	3.75 USD	387.01%
2016 Q3	0.77 USD	-8.33%
2016 Q2	0.84 USD	1500.0%
2016 FY	- USD	2982.35%
2015 Q4	0.08 USD	112.31%
2015 FY	- USD	109.39%
2015 Q3	-0.65 USD	-22.64%
2015 Q2	-0.53 USD	-138.41%
2015 Q1	1.38 USD	453.85%
2014 Q3	-0.65 USD	-209.52%
2014 FY	- USD	-217.54%
2014 Q4	-0.39 USD	40.0%
2014 Q2	-0.21 USD	30.0%
2014 Q1	-0.30 USD	-30.43%
2013 Q2	0.07 USD	115.87%
2013 Q1	-0.45 USD	-95.65%
2013 Q3	0.05 USD	-35.99%
2013 FY	- USD	68.85%
2013 Q4	-0.23 USD	-603.28%
2012 Q3	-3.14 USD	0.0%
2012 Q4	-0.23 USD	92.68%
2012 FY	- USD	0.0%

Peer Eps Comparison of Eagle Pharmaceuticals, Inc.

Name	Eps	Eps Difference
Bright Green Corporation	-0.07 USD	3855.102%
BioQuest Corp.	- USD	-Infinity%
Clever Leaves Holdings Inc.	-11.42 USD	124.168%
Guardion Health Sciences, Inc.	0.12 USD	-2200.0%
GSRX Industries Inc.	- USD	-Infinity%
High Sierra Technologies, Inc.	-0.02 USD	17568.354%
Instadose Pharma Corp.	- USD	-Infinity%